See also this year's filing and all EDGAR filings for this company.
PDF Report 0001618835_2023_Evofem_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001618835, Evofem Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 12,699,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,940,000 |
| 3 | remainder_Assets | 8,524,000 |
| 4 | LiabilitiesCurrent | 93,830,000 |
| 5 | LiabilitiesNoncurrent | 3,133,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 4,450,074 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,427,443 |
| 9 | ResearchAndDevelopmentExpense | 27,378,665 |
| 10 | remainder_Expenses | 72,473,235 |
| 11 | remainder_Revenues | 59,591,866 |
| 12 | remainder_NetIncome | -10,580,783 |
| 13 | remainder_ComprehensiveNetIncome | 241,183,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,163,000 |
| 1 | Liabilities | 96,963,000 |
| 2 | Expenses | 131,729,417 |
| 3 | Revenues | 59,591,866 |
| 4 | StockholdersEquity | -71,800,000 |
| 5 | NetIncome | -82,718,334 |
| 6 | ComprehensiveNetIncome | 37,873,166 |
| 7 | BaseVar | 282,605,533 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.94 |
| 9 | EconomicCapitalRatio | 1.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
